NCT01970644

Neurocognition After Gamma Knife Radiosurgery for Multiple Brian Metastases

Extracted Fields (from Registry)
Protocol IDNCT01970644
Registration Date2013-10-28
StatusTerminated
SponsorCancerCare Manitoba
CountryCanada
Industrynot industry
Blindingunblinded
Center Typesingel-center RCT
Scopenational RCT
First Patient In2014-04-01
Last Patient Out2015-09-01
Publicationn
Gender %ALL
Mean Age18 Years -
LLM Classifications (Side-by-Side)
Field OPENAI
gpt-4o
3339ms / 8568 tok
CLAUDE
claude-sonnet-4-20250514
5573ms / 10044 tok
GLM
glm-5.1
6431ms / 8726 tok
Review
rct_type N/A N/A N/A OK
cancer_status Cancer Cancer Cancer OK
non_cancer_spec N/A N/A N/A OK
setting_patient outpatient outpatient outpatient OK
setting_place hospital hospital hospital OK
feasibility N/A N/A N/A OK
intervention_pharmacologic no no no OK
intervention_chemo_immuno_radio yes yes yes OK
intervention_complementary no no no OK
intervention_device no no no OK
intervention_psychological no no no OK
intervention_complex no no no OK
intervention_acp no no no OK
intervention_music no no no OK
intervention_screening no no no OK
intervention_palliative no no no OK
intervention_education no no no OK
intervention_digital no no no OK
intervention_other no no no OK
outcome_symptom no no → no
shaky reasoning
✓ Unanimous Initial: no Requery: no — The trial focuses on neurocognitive outcomes and quality of life, without direct assessment of specific symptoms like pain, anxiety or depression using validated symptom instruments.
no no → no
shaky reasoning
✓ Unanimous Initial: no Requery: no — The study measures neurocognitive function (HVLT-R, TMT, COWAT, etc.) and adverse events (CTCAE), but does not assess specific symptoms like pain, nausea, dyspnea, fatigue, anxiety, depression, or use symptom burden scales.
no yes
shaky reasoning
✓ Unanimous Initial: yes
OK
outcome_qol yes yes yes OK
outcome_dignity no no no OK
outcome_cost no no no OK
outcome_other yes yes yes OK
pharmacologic_sub N/A N/A N/A OK
Back to Studies